Establishment of Doxorubicin Resistant Human Osteosarcoma Cell Lines
Journal of Pioneering Medical Sciences · 2026-05-05 · 15 (04) · 111-113
DOI: 10.47310/jpms2026150416 ↗At a glance
Journal article in Journal of Pioneering Medical Sciences, published online on 2026-05-05. Written by Zhen Li and 1 co-authors.
Abstract (original language)
Background
Osteosarcoma (OS) is the most frequent highly malignant primary bone tumour in children and adolescence. The underlying mechanisms of OS progression behind multi-drug resistance s was still not completely clear, and needed to uncover the underlying mechanisms of chemoresistance to develop more effective therapeutic strategies.
Objective
The purpose of this study is to establish drug resistance OS MG-63 and U2OS cells induced by DOX, which will support further investigation into the underlying mechanisms.
Method
MG63 and U2OS cell lines were treated with repeated exposure to gradually increasing concentrations of doxorubicin. The IC₅₀ value of doxorubicin resistance MG63 and U2OS and the parental cells were detected by MTT.
Results
The IC₅₀ value (106512.32 ng/ml for MG-63, 141715.28 ng/ml for U2OS) of doxorubicin resistance MG63 and U2OS were18.86 and 3.1-fold that for the parental cells (p < 0.001, both).
Conclusion
Our established doxorubicin-resistant cell lines should be a useful tool for identifying new mechanisms of drug resistance and new drug targets in osteosarcoma.
Cite
APA
Li, Z., & Dong, S. (2026). Establishment of Doxorubicin Resistant Human Osteosarcoma Cell Lines. Journal of Pioneering Medical Sciences, 15(04), 111-113. https://doi.org/10.47310/jpms2026150416
Vancouver
Li Z, Dong S. Establishment of Doxorubicin Resistant Human Osteosarcoma Cell Lines. Journal of Pioneering Medical Sciences. 2026;15(04):111-113. doi:10.47310/jpms2026150416
BibTeX
@article{Li2026,
author = {Li, Zhen and Dong, Suwei},
title = {Establishment of Doxorubicin Resistant Human Osteosarcoma Cell Lines},
journal = {Journal of Pioneering Medical Sciences},
year = {2026},
volume = {15},
number = {04},
pages = {111--113},
doi = {10.47310/jpms2026150416}
}
EUVIMED